Monitor for follow-up data releases or peer-reviewed publication of CAPTAIN trial results, which could support reimbursement expansion or broader adoption. This event alone does not justify a trading move.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Apr 1 $6.53entry
- T+1 · 8mo ago −1.53%α −1.61% · $6.43
- T+5 · 7mo ago −1.38%α −5.14% · $6.44
- T+20 · 7mo ago +0.31%α −9.42% · $6.55
- T+60 · 5mo ago +0.92%α −12.46% · $6.59
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Profound Medical announced that its TULSA-PRO system and the MRI-guided TULSA Procedure will be featured in multiple presentations at the 2026 Society of Interventional Radiology (SIR) Annual Meeting, including data from the CAPTAIN trial and real-world clinical experience. While the event increases visibility for the technology, no new clinical results, regulatory decisions, or commercial updates were disclosed. This is a promotional awareness event, not a material clinical or regulatory milestone.
Key Facts
- TULSA-PRO and TULSA Procedure will be highlighted in multiple oral and featured presentations at SIR 2026 Annual Meeting in Toronto (April 11–15, 2026).
- Presentations include CAPTAIN trial data (Level 1 evidence), real-world experience, and a meta-analysis of oncologic and functional outcomes.
- No new clinical data, FDA decisions, or commercial updates were released.
- The event is a scientific conference presentation, not a regulatory or commercial catalyst.
Financial Impact
Minimal near-term financial impact; potential long-term benefit from increased physician awareness and adoption.
Risk Factors
- Increased visibility does not guarantee adoption or reimbursement.
- Forward-looking statements in the release are speculative and not guaranteed.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3266591 |
Track record
22 reports on PROF
2 of 3 bullish or bearish reports moved the stock their way by T+20. Best: +25.61% at T+60 after the Mar 5, 2026 report. 3 of 4 went positive at some point.
Filters
- Nov 12, 20264d ago 8-K Neutral 3/10 Entry $7.44 Now $7.34 −1.34% settles Dec 11
- Nov 9, 20267d ago 8-K Neutral 2/10 Entry $7.34 Now $7.34 +0.00% settles Dec 8
- Nov 5, 202611d ago 8-K Bearish 5/10 Entry $7.21 Now $7.34 −1.80% settles Dec 7
- Nov 3, 202613d ago 8-K Neutral 4/10 Entry $7.16 Now $7.34 +2.51% settles Dec 3
- Oct 30, 202617d ago Press Release Neutral 4/10 Entry $6.57 Now $7.34 +11.72% settles Nov 30
- Oct 22, 202625d ago 8-K Neutral 2/10 Entry $5.56 Now $7.34 +32.01% settles Nov 20
- Oct 14, 20264w ago 8-K Neutral 3/10 Entry $6.62 to $7.68 Now $7.34 +10.88% ▲ +16.01% +18.57% vs SPY
- Oct 9, 20265w ago 8-K Neutral 3/10 Entry $6.90 to $7.01 Now $7.34 +6.38% ▲ +1.59% +7.15% vs SPY
- Oct 7, 20265w ago 8-K Bullish 7/10 Entry $6.91 to $7.16 Now $7.34 +6.22% ▲ +3.62% +8.91% vs SPY
- Sep 3, 202610w ago 8-K Neutral 2/10 Entry $6.89 to $6.03 Now $7.34 +6.53% ▼ −12.48% −13.08% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers